{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T22:06:58Z","timestamp":1792793218991,"version":"4.5.0"},"reference-count":41,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2022,9,23]],"date-time":"2022-09-23T00:00:00Z","timestamp":1663891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"PTC Therapeutics (United States)"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Aromatic amino acid decarboxylase (AADC) deficiency is a rare monogenic disease due to mutations in the ddc gene producing AADC, a homodimeric pyridoxal 5\u2032-phosphate-dependent enzyme. The disorder is often fatal in the first decade and is characterized by profound motor impairments and developmental delay. In the last two years, there has been a net rise in the number of patients and variants identified, maybe also pushed by the ongoing gene therapy trials. The majority of the identified genotypes are compound heterozygous (about 70%). Efforts are underway to reach early diagnosis, find possible new markers\/new fast methods, and predict clinical outcome. However, no clear correlation of genotype-to-phenotype exists to date. Nevertheless, for homozygous patients, reliable results have been obtained using genetic methods combined with available computational tools on crystal structures corroborated by biochemical investigations on recombinant homodimeric AADC variants that have been obtained and characterized in solution. For these variants, the molecular basis for the defect has been suggested and validated, since it correlates quite well with mildness\/severity of the homozygous phenotype. Instead, prediction for compound heterozygous patients is more difficult since complementation effects could happen. Here, by analyzing the existing literature on compound heterozygosity in AADC deficiency and other genetic disorders, we highlight that, in order to assess pathogenicity, the measurement of activity of the AADC heterodimeric variant should be integrated by bioinformatic, structural, and functional data on the whole protein constellation theoretically present in such patients. A wider discussion on symptomatic heterozygosity in AADC deficiency is also presented.<\/jats:p>","DOI":"10.3390\/ijms231911238","type":"journal-article","created":{"date-parts":[[2022,9,25]],"date-time":"2022-09-25T23:13:27Z","timestamp":1664147607000},"page":"11238","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Compound Heterozygosis in AADC Deficiency and Its Complex Phenotype in Terms of AADC Protein Population"],"prefix":"10.3390","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3803-9555","authenticated-orcid":false,"given":"Giovanni","family":"Bisello","sequence":"first","affiliation":[{"name":"Department of Neuroscience, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of Verona, Strada le Grazie 8, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2337-9928","authenticated-orcid":false,"given":"Mariarita","family":"Bertoldi","sequence":"additional","affiliation":[{"name":"Department of Neuroscience, Biomedicine and Movement Sciences, Section of Biological Chemistry, University of Verona, Strada le Grazie 8, 37134 Verona, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/BF01799380","article-title":"Aromatic amino acid decarboxylase deficiency in twins","volume":"13","author":"Hyland","year":"1990","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13023-016-0522-z","article-title":"Consensus guideline for the diagnosis and treatment of aromatic l-amino acid decarboxylase (AADC) deficiency","volume":"12","author":"Wassenberg","year":"2017","journal-title":"Orphanet J. Rare Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ymgme.2019.03.009","article-title":"Aromatic amino acid decarboxylase deficiency: Molecular and metabolic basis and therapeutic outlook","volume":"127","author":"Himmelreich","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ymgme.2021.08.011","article-title":"Compound heterozygosis in AADC deficiency: A complex phenotype dissected through comparison among heterodimeric and homodimeric AADC proteins","volume":"134","author":"Longo","year":"2021","journal-title":"Mol. Genet. Metab"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"134ra161","DOI":"10.1126\/scitranslmed.3003640","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency","volume":"4","author":"Hwu","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S2352-4642(17)30125-6","article-title":"Efficacy and safety of AAV2 gene therapy in children with aromatic L-amino acid decarboxylase deficiency: An open-label, phase 1\/2 trial","volume":"1","author":"Chien","year":"2017","journal-title":"Lancet Child Adolesc. Health"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e14712","DOI":"10.15252\/emmm.202114712","article-title":"Gene therapy in the putamen for curing AADC deficiency and Parkinson\u2019s disease","volume":"13","author":"Hwu","year":"2021","journal-title":"EMBO Mol. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.ymthe.2021.11.005","article-title":"Long-term efficacy and safety of eladocagene exuparvovec in patients with AADC deficiency","volume":"30","author":"Tai","year":"2022","journal-title":"Mol. Ther."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/brain\/awy331","article-title":"Gene therapy improves motor and mental function of aromatic l-amino acid decarboxylase deficiency","volume":"142","author":"Kojima","year":"2019","journal-title":"Brain"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"fcab078","DOI":"10.1093\/braincomms\/fcab078","article-title":"Dopaminergic restoration of prefrontal cortico-putaminal network in gene therapy for aromatic l-amino acid decarboxylase deficiency","volume":"3","author":"Onuki","year":"2021","journal-title":"Brain Commun."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"651","DOI":"10.3171\/2020.6.JNS201564","article-title":"Use of a novel ball-joint guide array for magnetic resonance imaging-guided cannula placement and convective delivery: Technical note","volume":"135","author":"Bankiewicz","year":"2020","journal-title":"J. Neurosurg."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1038\/s41467-021-24524-8","article-title":"Gene therapy for aromatic L-amino acid decarboxylase deficiency by MR-guided direct delivery of AAV2-AADC to midbrain dopaminergic neurons","volume":"12","author":"Pearson","year":"2021","journal-title":"Nat. Commun."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pediatrneurol.2019.11.022","article-title":"Prevalence of Aromatic l-Amino Acid Decarboxylase Deficiency in At-Risk Populations","volume":"106","author":"Hyland","year":"2020","journal-title":"Pediatr. Neurol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"5429","DOI":"10.1093\/hmg\/ddu266","article-title":"A comprehensive picture of the mutations associated with aromatic amino acid decarboxylase deficiency: From molecular mechanisms to therapy implications","volume":"23","author":"Montioli","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10545-011-9340-6","article-title":"Molecular insights into the pathogenicity of variants associated with the aromatic amino acid decarboxylase deficiency","volume":"34","author":"Montioli","year":"2011","journal-title":"J. Inherit. Metab. Dis."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.bbapap.2016.03.011","article-title":"The novel R347g pathogenic mutation of aromatic amino acid decarboxylase provides additional molecular insights into enzyme catalysis and deficiency","volume":"1864","author":"Montioli","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"108263","DOI":"10.1016\/j.abb.2020.108263","article-title":"New variants of AADC deficiency expand the knowledge of enzymatic phenotypes","volume":"682","author":"Montioli","year":"2020","journal-title":"Arch. Biochem. Biophys."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/hmg\/ddt011","article-title":"S250F variant associated with aromatic amino acid decarboxylase deficiency: Molecular defects and intracellular rescue by pyridoxine","volume":"22","author":"Montioli","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/iub.1718","article-title":"Heterozygosis in aromatic amino acid decarboxylase deficiency: Evidence for a positive interallelic complementation between R347Q and R358H mutations","volume":"70","author":"Montioli","year":"2018","journal-title":"IUBMB Life"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ymgme.2019.05.004","article-title":"A novel compound heterozygous genotype associated with aromatic amino acid decarboxylase deficiency: Clinical aspects and biochemical studies","volume":"127","author":"Montioli","year":"2019","journal-title":"Mol. Genet. Metab."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4480","DOI":"10.1073\/pnas.81.14.4480","article-title":"Interallelic complementation in an inborn error of metabolism: Genetic heterogeneity in argininosuccinate lyase deficiency","volume":"81","author":"McInnes","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1093\/hmg\/6.9.1457","article-title":"Expression and kinetic characterization of methylmalonyl-CoA mutase from patients with the mut-phenotype: Evidence for naturally occurring interallelic complementation","volume":"6","author":"Janata","year":"1997","journal-title":"Hum. Mol. Genet."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1098-1004(1997)9:1<1::AID-HUMU1>3.0.CO;2-E","article-title":"Mutations in mut methylmalonic acidemia: Clinical and enzymatic correlations","volume":"9","author":"Ledley","year":"1997","journal-title":"Hum. Mutat."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1110\/ps.062416606","article-title":"Statistical potential for assessment and prediction of protein structures","volume":"15","author":"Shen","year":"2006","journal-title":"Protein Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ymgme.2016.01.004","article-title":"Co-expression of phenylalanine hydroxylase variants and effects of interallelic complementation on in vitro enzyme activity and genotype-phenotype correlation","volume":"117","author":"Shen","year":"2016","journal-title":"Mol. Genet. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1002\/humu.22320","article-title":"Tetrahydrobiopterin, its mode of action on phenylalanine hydroxylase, and importance of genotypes for pharmacological therapy of phenylketonuria","volume":"34","author":"Heintz","year":"2013","journal-title":"Hum. Mutat."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.bbadis.2006.02.001","article-title":"Co-expression of different subunits of human phenylalanine hydroxylase: Evidence of negative interallelic complementation","volume":"1762","author":"Leandro","year":"2006","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.bbadis.2011.02.001","article-title":"Heterotetrameric forms of human phenylalanine hydroxylase: Co-expression of wild-type and mutant forms in a bicistronic system","volume":"1812","author":"Leandro","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.ymgme.2018.06.011","article-title":"Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria","volume":"125","author":"Himmelreich","year":"2018","journal-title":"Mol. Genet. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/s41436-018-0081-x","article-title":"Allelic phenotype values: A model for genotype-based phenotype prediction in phenylketonuria","volume":"21","author":"Garbade","year":"2019","journal-title":"Genet. Med."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.cca.2018.02.035","article-title":"Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population","volume":"481","author":"Wang","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Brennenstuhl, H., Didiasova, M., Assmann, B., Bertoldi, M., Molla, G., Jung-Klawitter, S., Kuseyri H\u00fcbschmann, O., Schr\u00f6ter, J., Opladen, T., and Tikkanen, R. (2020). Succinic Semialdehyde Dehydrogenase Deficiency: In Vitro and In Silico Characterization of a Novel Pathogenic Missense Variant and Analysis of the Mutational Spectrum of. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21228578"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.26423","article-title":"Integrative Approach to Predict Severity in Nonketotic Hyperglycinemia","volume":"92","author":"Olivella","year":"2022","journal-title":"Ann. Neurol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1002\/ana.24485","article-title":"Biochemical and molecular predictors for prognosis in nonketotic hyperglycinemia","volume":"78","author":"Swanson","year":"2015","journal-title":"Ann. Neurol."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Farris, J., Calhoun, B., Alam, M.S., Lee, S., and Haldar, K. (2020). Large scale analyses of genotype-phenotype relationships of glycine decarboxylase mutations and neurological disease severity. PLoS Comput. Biol., 16.","DOI":"10.1371\/journal.pcbi.1007871"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"5998","DOI":"10.1093\/hmg\/ddu329","article-title":"S81L and G170R mutations causing Primary Hyperoxaluria type I in homozygosis and heterozygosis: An example of positive interallelic complementation","volume":"23","author":"Montioli","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/nsb1101-963","article-title":"Structural insight into Parkinson\u2019s disease treatment from drug-inhibited DOPA decarboxylase","volume":"8","author":"Burkhard","year":"2001","journal-title":"Nat. Struct. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"226","DOI":"10.2174\/0929867324666161123093339","article-title":"New Insights Emerging from Recent Investigations on Human Group II Pyridoxal 5\u2032-Phosphate Decarboxylases","volume":"24","author":"Paiardini","year":"2017","journal-title":"Curr. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e10953","DOI":"10.1097\/MD.0000000000010953","article-title":"When dysphoria is not a primary mental state: A case report of the role of the aromatic L-aminoacid decarboxylase","volume":"97","author":"Portaro","year":"2018","journal-title":"Medicine"},{"key":"ref_40","first-page":"39","article-title":"Report of two never treated adult sisters with aromatic L-amino Acid decarboxylase deficiency: A portrait of the natural history of the disease or an expanding phenotype?","volume":"15","author":"Leuzzi","year":"2015","journal-title":"JIMD Rep."},{"key":"ref_41","first-page":"1","article-title":"Natural History of Aromatic L-Amino Acid Decarboxylase Deficiency in Taiwan","volume":"40","author":"Hwu","year":"2018","journal-title":"JIMD Rep."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11238\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:38:36Z","timestamp":1760143116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/23\/19\/11238"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,23]]},"references-count":41,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["ijms231911238"],"URL":"https:\/\/doi.org\/10.3390\/ijms231911238","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,23]]}}}